Observed arrival · 2026-09-09
What Did You Take? — A Compound-by-Compound Risk Reference
An openly readable harm-reduction reference that compares twelve compounds across dependence, toxicity, documented harm, long-term risk, evidence quality, and product integrity.
Field notes
The reference separates six dimensions of risk instead of collapsing them into a single verdict: dependence liability, acute toxicity, documented serious harm, long-term or irreversible risk, evidence quality, and product integrity. Its visible coverage includes twelve compounds, from creatine and kratom to gray-market GLP-1s, RAD-140, phenibut, and tianeptine. Supporting sections explain the rating method, list sources, publish an editorial policy, and provide a corrections log.
Observed signals
Read the marks
Editorial observations of this landing page, not a rating.
One card from the complete issue